Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach

Journal of Comparative Effectiveness Research
Nicolas W ShammasJihad Mustapha

Abstract

The incremental cost of peripheral orbital atherectomy system (OAS) plus balloon angioplasty (BA) versus BA-only for critical limb ischemia was estimated. A deterministic simulation model used clinical and healthcare utilization data from the CALCIUM 360° trial and current cost data. Incremental cost of OAS + BA versus BA-only included differential utilization during the procedure and adverse-event costs at 3, 6 and 12-months. For every 100 procedures, incremental annual costs to the hospital were US$350,930 lower with OAS + BA compared with BA-only. Despite higher upfront costs, savings were realized due to reduced need for revascularization, amputation and end-of-life care over 6-12-month postoperative period. Atherectomy with OAS prior to BA was associated with cost savings to the hospital.

References

Jun 3, 1999·Annual Review of Public Health·P DiehrD Y Lin
May 20, 2004·Health Services Research·Berhanu Alemayehu, Kenneth E Warner
Mar 11, 2005·Archives of Physical Medicine and Rehabilitation·Timothy R DillinghamAndrew D Shore
May 30, 2006·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·E FagliaA Morabito
Jan 16, 2007·Journal of Vascular Surgery·L NorgrenUNKNOWN TASC II Working Group
Aug 3, 2007·The Journal of Bone and Joint Surgery. American Volume·Ellen J MacKenzieAndrew R Burgess
Mar 29, 2008·Journal of Vascular Surgery·Marcello RomitiNelson De Luccia
Dec 19, 2008·Cardiovascular and Interventional Radiology·Marc BosiersUNKNOWN AMS INSIGHT Investigators
Dec 30, 2008·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R FerraresiG B Danzi
Jul 25, 2009·JACC. Cardiovascular Interventions·Osamu IidaSeiki Nagata
Sep 30, 2009·Journal of Vascular Surgery·Mark F ConradGlenn M LaMuraglia
Dec 17, 2009·Aging Clinical and Experimental Research·Leena RemesPäivi Rautava
Aug 31, 2010·Journal of Rehabilitation Research and Development·David K BloughGayle E Reiber
Dec 18, 2010·Journal of Vascular Surgery·Antonia J HenryLouis L Nguyen
Feb 12, 2011·Journal of Cardiovascular Translational Research·George L AdamsEphraim M Sparrow
Dec 8, 2011·Circulation. Cardiovascular Quality and Outcomes·Philip P GoodneyElliott S Fisher
Jan 14, 2012·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·O IidaM Uematsu
Aug 3, 2012·Journal of Vascular Surgery·Neal R BarshesUNKNOWN Model To Optimize Healthcare Value in Ischemic Extremities 1 (MOVIE) Study Collaborators
Aug 7, 2012·The International Journal of Lower Extremity Wounds·Ayad Jindeel, Kenneth A Narahara
Aug 16, 2012·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Nicolas W ShammasNilesh Balar
Feb 9, 2013·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Masatsugu NakanoYusuke Miyashita
Jun 6, 2013·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Tony DasGeorge L Adams
Nov 12, 2013·Vascular and Endovascular Surgery·Kakra HughesThomas Obisesan
Apr 5, 2014·Journal of Graduate Medical Education·Aditee P NarayanKathleen A McGann
Sep 12, 2015·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Louis P GarrisonRalph G Brindis
Jan 7, 2016·The American Journal of Cardiology·Sidakpal S PanaichApurva O Badheka
Mar 9, 2015·Journal of Health Economics and Outcomes Research·Eugene A GrossiJohn A Rizzo

❮ Previous
Next ❯

Citations

Sep 5, 2020·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Krishna JainPhillip Key

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation
dissections
percutaneous transluminal atherectomy
dissection
percutaneous transluminal angioplasty

Software Mentioned

TreeAge Pro
TreeAge
Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.